Neuroprotective agents in schizophrenia and affective disorders.
about
How should we intervene in psychosis risk syndromes?Research in people with psychosis risk syndrome: a review of the current evidence and future directionsNeuroendocrine profile in a rat model of psychosocial stress: relation to oxidative stress.Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach.Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries.Recombinant human erythropoietin in amyotrophic lateral sclerosis: a pilot study of safety and feasibility.Clozapine protects PC-12 cells from death due to oxidative stress induced by hydrogen peroxide via a cell-type specific mechanism involving inhibition of extracellular signal-regulated kinase phosphorylation.Critics on "adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: a placebo-controlled pilot study"The role of neuroinflammation and neurovascular dysfunction in major depressive disorder.
P2860
Q27008060-D33BA3B9-B5C6-4D8B-8304-3EA70AABDDC8Q30475598-F81DD059-4831-416E-AD3F-03C8C1E99050Q36702534-F591FB40-E1CC-4920-B9A1-BA7FC5F9CDF2Q36904879-7657A5E9-A20D-4579-81AC-A765098608F8Q37821806-AA5CBB4E-BAA7-444D-9722-54CACC9584A1Q38154625-ACC8B1A0-488F-459B-BC5E-6182A1B99DEEQ38209914-8B76CAE2-F3E8-4C94-BE92-A63897DBB1DEQ38432879-A0A7BFF2-AE76-4D4F-8481-C7507C543418Q39842108-1E591230-DB75-43FA-A9A1-B00152E4509FQ41513149-37CB4458-2E5A-4953-B2ED-5DFD2CE1B68CQ55163955-875F35FF-1682-455B-855A-0D43A2BB2367
P2860
Neuroprotective agents in schizophrenia and affective disorders.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Neuroprotective agents in schizophrenia and affective disorders.
@ast
Neuroprotective agents in schizophrenia and affective disorders.
@en
type
label
Neuroprotective agents in schizophrenia and affective disorders.
@ast
Neuroprotective agents in schizophrenia and affective disorders.
@en
prefLabel
Neuroprotective agents in schizophrenia and affective disorders.
@ast
Neuroprotective agents in schizophrenia and affective disorders.
@en
P2093
P2860
P356
P1476
Neuroprotective agents in schizophrenia and affective disorders.
@en
P2093
Axel Hinzpeter
Karolina Leopold
Martin Schaefer
Michael Krebs
P2860
P304
P356
10.1517/14656566.7.7.837
P407
P577
2006-05-01T00:00:00Z